Inventor · disambiguated record
Guillaume Brandt
Also filed as: BRANDT GUILLAUME
5 granted patents·2 pending applications·80 citations·filing 2010–2017
77Inventor score
Files withIDENIX PHARMACEUTICALS INC3BOGEN STEPHANE1CENTRE NAT RECH SCIENT1DOUSSON CYRIL B1IDENIX PHARMACEUTICALS LLC1
Top patents by PatentIndex Score
7 records- 0195US8362068B25,5-fused arylene or heteroarylene hepatitis C virus inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2010·Granted Jan 29, 2013·66 cites·53 claims
- 0284US9187496B25,5-fused arylene or heteroarylene hepatitis C virus inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2012·Granted Nov 17, 2015·8 cites·45 claims
- 0380US10202411B23′-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCVIDENIX PHARMACEUTICALS LLC·Filed 2015·Granted Feb 12, 2019·3 cites·29 claims
- 0478US10899788B2Cyclic phosphate substituted nucleoside compounds and methods of use thereof for the treatment of viral diseasesBOGEN STEPHANE·Filed 2017·Granted Jan 26, 2021·3 cites·17 claims
- 0554US2014271547A1Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcvIDENIX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0652US10231986B2Amino acid phosphoramidate pronucleotides of 2′-cyano, azido and amino nucleosides for the treatment of HCVCENTRE NAT RECH SCIENT·Filed 2015·Granted Mar 19, 2019·0 cites·31 claims
- 0738US2012252721A1Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitorDOUSSON CYRIL B·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →